ArticleFrontiers in pediatrics2025
Combination of echocardiography with systemic hemodynamic parameters for early risk stratification of hemodynamically significant patent ductus arteriosus in preterm infants.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cardiac output measurement in Fontan circulation: Challenges and potential emerging solutions.Annals of pediatric cardiologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hemodynamically significant patent ductus arteriosus (hsPDA) is a major contributor to morbidity and mortality in extremely preterm infants. Both echocardiographic assessment and systemic hemodynamic monitoring have emerged as valuable tools for evaluating cardiovascular status during the early postnatal period. This study aimed to evaluate whether echocardiographic and systemic hemodynamic parameters within 72 hours can predict the development of hsPDA in preterm infants. Methods: In this prospective study, 98 infants born at our institution between October 2022 and March 2025 were enrolled based on inclusion criteria of gestational age ≤32 weeks and birth weight ≤1,500 g. Hemodynamic monitoring was conducted using the Non-Invasive Cardiac System (NICaS) at 24, 48, and 72 hours after birth, each followed immediately by echocardiographic evaluation. Results: Among 98 preterm infants, 85 had patent ductus arteriosus (PDA) at 24 hours, with 30 progressing to hsPDA. The hsPDA group had significantly lower gestational age and birth weight. Maternal eclampsia or preeclampsia, placental abruption, neonatal asphyxia, alveolar surfactant need, mechanical ventilation within 72 hours, and higher fluid intake in the first 24 hours were more frequent in this group. These infants required prolonged respiratory support and parenteral nutrition, and showed higher rates of intraventricular hemorrhage (IVH) and bronchopulmonary dysplasia (BPD). Compared to non-hsPDA infants, those with hsPDA had larger ductus arteriosus (DA) diameters, higher DA diameter/weight ratios at 48 and 72 hours, and elevated left atrium-to-aortic root (LA/Ao) ratios at 24, 48, and 72 hours. Stroke index (SI), cardiac output index (CI), and total body water percent (TBW%) were increased, while total peripheral resistance index (TPRI) was reduced at 48 and 72 hours. Multivariate analysis identified maternal eclampsia/preeclampsia, surfactant use, DA diameter-to-weight ratio, LA/Ao, and TBW% at 48 and 72 hours as independent risk factors. A combined model achieved high predictive accuracy (AUC = 0.981, sensitivity = 100%, specificity = 90.0%). Conclusion: This study demonstrated that combining echocardiographic parameters with systemic hemodynamic indicators at 72 hours of life provides significant predictive value for identifying preterm infants with a gestational age ≤32 weeks and birth weight ≤1,500 g who are at risk of developing hsPDA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.